FEBRUARY 24-25, 2015 • HOTEL KABUKI • SAN FRANCISCO, CA

The oncology marketplace is a competitive environment in which a strong commercialization strategy is essential for product success. As more products enter the pipeline, how do you ensure that market access is attained?

This in-depth and dynamic event examines the implications of recent product approvals (such as Sovaldi) on their value demonstration in the oncology marketplace.

Join us for our 2015 event in San Francisco to maximize market access and meet commercial goals for both new and existing oncology therapies. Benefit and learn from peers in cross-functional roles within oncology to:

• Establish a product value story beyond cost
• Explore ASCO’s method of integrating cost into evidence-based medicine to define value
• Discuss motivating influences behind therapy adoption with providers and payers
• Examine key internal considerations to successfully execute a global product launch

• Incorporate medical affairs to connect development and commercialization and ensure launch success
• Cultivate methods to partner products with CDx during the therapy development stage to justify process and highlight value
• Learn strategies for emerging companies to cultivate a strong corporate identity